David Abrams decreased its stake in Teva Pharmaceutical Inds Ltd (TEVA) by 8.7% based on its latest 2017Q4 regulatory filing with the SEC. Abrams Capital Management Lp sold 1.88M shares as the company’s stock declined 11.04% with the market. The hedge fund run by David Abrams held 19.74 million shares of the major pharmaceuticals company at the end of 2017Q4, valued at $374.13 million, down from 21.62 million at the end of the previous reported quarter. Abrams Capital Management Lp who had been investing in Teva Pharmaceutical Inds Ltd for a number of months, seems to be less bullish one the $21.24 billion market cap company. The stock decreased 0.67% or $0.14 during the last trading session, reaching $20.86. About 952,173 shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 49.50% since May 23, 2017 and is downtrending. It has underperformed by 61.05% the S&P500.
Syntal Capital Partners Llc decreased its stake in Parsley Energy Inc (PE) by 46.73% based on its latest 2017Q4 regulatory filing with the SEC. Syntal Capital Partners Llc sold 165,002 shares as the company’s stock declined 8.80% with the market. The institutional investor held 188,066 shares of the energy company at the end of 2017Q4, valued at $3.48 million, down from 353,068 at the end of the previous reported quarter. Syntal Capital Partners Llc who had been investing in Parsley Energy Inc for a number of months, seems to be less bullish one the $9.82 billion market cap company. The stock decreased 0.06% or $0.02 during the last trading session, reaching $31. About 600,677 shares traded. Parsley Energy, Inc. (NYSE:PE) has declined 12.13% since May 23, 2017 and is downtrending. It has underperformed by 23.68% the S&P500.
Analysts await Teva Pharmaceutical Industries Limited (NYSE:TEVA) to report earnings on August, 2. They expect $0.59 earnings per share, down 40.40% or $0.40 from last year’s $0.99 per share. TEVA’s profit will be $600.75 million for 8.84 P/E if the $0.59 EPS becomes a reality. After $0.91 actual earnings per share reported by Teva Pharmaceutical Industries Limited for the previous quarter, Wall Street now forecasts -35.16% negative EPS growth.
Among 35 analysts covering Teva Pharma (NYSE:TEVA), 9 have Buy rating, 8 Sell and 18 Hold. Therefore 26% are positive. Teva Pharma had 153 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was upgraded by Morgan Stanley on Friday, December 15 to “Hold”. The firm earned “Outperform” rating on Wednesday, December 7 by Oppenheimer. On Friday, January 20 the stock rating was downgraded by JP Morgan to “Neutral”. RBC Capital Markets maintained it with “Buy” rating and $3800 target in Friday, June 16 report. The firm has “Buy” rating by Goldman Sachs given on Monday, August 10. The rating was maintained by Morgan Stanley with “Underweight” on Thursday, October 5. The firm earned “Underweight” rating on Monday, November 13 by JP Morgan. The rating was downgraded by Wells Fargo to “Market Perform” on Monday, January 9. The firm has “Underweight” rating by PiperJaffray given on Friday, February 9. As per Tuesday, January 31, the company rating was maintained by Barclays Capital.
More notable recent Teva Pharmaceutical Industries Limited (NYSE:TEVA) news were published by: Globes.Co.Il which released: “Sun: TASE rises despite steep Teva fall” on May 06, 2018, also Globes.Co.Il with their article: “Teva on FDA name and shame list” published on May 21, 2018, Fool.com published: “Buffett Gets Even Greedier With Teva Pharmaceuticals. Time to Buy?” on May 18, 2018. More interesting news about Teva Pharmaceutical Industries Limited (NYSE:TEVA) were released by: 247Wallst.com and their article: “Is This the Turnaround Teva Has Been Waiting For?” published on May 03, 2018 as well as Streetinsider.com‘s news article titled: “Teva Pharma (TEVA) Fremanezumab PDUFA Date Extended Until September” with publication date: May 23, 2018.
Investors sentiment decreased to 1.01 in Q4 2017. Its down 0.12, from 1.13 in 2017Q3. It is negative, as 49 investors sold PE shares while 96 reduced holdings. 54 funds opened positions while 93 raised stakes. 251.44 million shares or 1.93% more from 246.67 million shares in 2017Q3 were reported. Gsa Ptnrs Llp reported 11,210 shares. Hsbc Holding Pcl holds 0% or 70,723 shares in its portfolio. World Invsts reported 1.71 million shares. Deutsche Fincl Bank Ag has invested 0.02% in Parsley Energy, Inc. (NYSE:PE). Commonwealth Of Pennsylvania School Empls Retrmt Sys has invested 0.01% in Parsley Energy, Inc. (NYSE:PE). Third Point Lc holds 1.22% or 5.75M shares. Texas-based Dimensional Fund Advisors LP has invested 0.01% in Parsley Energy, Inc. (NYSE:PE). Discovery Mgmt Ltd Liability Corp Ct has invested 2.57% in Parsley Energy, Inc. (NYSE:PE). Waddell And Reed holds 0.11% or 1.71 million shares. The Washington-based Parametric Limited Co has invested 0.01% in Parsley Energy, Inc. (NYSE:PE). Nelson Van Denburg & Campbell Wealth Mgmt Grp Inc Limited Liability Co stated it has 4,900 shares or 0.03% of all its holdings. Teacher Retirement Systems Of Texas holds 0.01% or 59,894 shares. 5.60M are owned by Van Eck Assocs. Public Employees Retirement Association Of Colorado stated it has 39,661 shares or 0.01% of all its holdings. Kbc Gru Nv holds 74,248 shares or 0.02% of its portfolio.
Since February 26, 2018, it had 3 insider purchases, and 6 sales for $3.29 million activity. The insider Roberts Colin sold 7,500 shares worth $212,175. Another trade for 10,000 shares valued at $259,900 was made by ALAMEDDINE A R on Tuesday, February 27. Gallagher Matthew also sold $4.54M worth of Parsley Energy, Inc. (NYSE:PE) shares. Sheffield Bryan bought $4.99 million worth of Parsley Energy, Inc. (NYSE:PE) on Monday, February 26. Another trade for 41,681 shares valued at $1.33M was made by Hinson Mike on Tuesday, May 8. Dalton Ryan sold $1.93M worth of stock or 60,742 shares.
Another recent and important Parsley Energy, Inc. (NYSE:PE) news was published by Seekingalpha.com which published an article titled: “Parsley Energy (PE) Q1 2018 Results – Earnings Call Transcript” on May 04, 2018.
Among 37 analysts covering Parsley Energy Inc (NYSE:PE), 29 have Buy rating, 0 Sell and 8 Hold. Therefore 78% are positive. Parsley Energy Inc had 144 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Equal-Weight” rating by Morgan Stanley on Wednesday, February 7. The firm has “Buy” rating given on Tuesday, January 12 by Topeka Capital Markets. The firm has “Overweight” rating by JP Morgan given on Tuesday, March 13. The stock of Parsley Energy, Inc. (NYSE:PE) has “Neutral” rating given on Wednesday, October 12 by Macquarie Research. The stock of Parsley Energy, Inc. (NYSE:PE) has “Buy” rating given on Friday, November 10 by RBC Capital Markets. UBS reinitiated Parsley Energy, Inc. (NYSE:PE) on Thursday, March 23 with “Buy” rating. As per Tuesday, January 30, the company rating was maintained by Credit Suisse. The company was maintained on Monday, June 26 by BMO Capital Markets. The stock has “Buy” rating by Bank of America on Tuesday, January 30. The stock has “Focus Stock” rating by Howard Weil on Monday, November 30.
Syntal Capital Partners Llc, which manages about $422.80M and $327.20M US Long portfolio, upped its stake in Raytheon Co (NYSE:RTN) by 3,551 shares to 8,103 shares, valued at $1.52 million in 2017Q4, according to the filing. It also increased its holding in Boeing Co (NYSE:BA) by 2,453 shares in the quarter, for a total of 6,594 shares, and has risen its stake in New York Times Cl A (NYSE:NYT).
Analysts await Parsley Energy, Inc. (NYSE:PE) to report earnings on August, 1. They expect $0.33 EPS, up 560.00% or $0.28 from last year’s $0.05 per share. PE’s profit will be $104.56M for 23.48 P/E if the $0.33 EPS becomes a reality. After $0.31 actual EPS reported by Parsley Energy, Inc. for the previous quarter, Wall Street now forecasts 6.45% EPS growth.